Publications in collaboration with researchers from University of Sfax (15)

2024

  1. Discovery of New Highly Potent Histamine H3 Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors

    ACS Chemical Neuroscience, Vol. 15, Núm. 18, pp. 3363-3383

2023

  1. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment

    International Journal of Molecular Sciences, Vol. 24, Núm. 11

2021

  1. Synthesis and Biological Assessment of PyrimidoTacrines as Promising Agents for Alzheimer's Disease Therapy

    ChemistrySelect, Vol. 6, Núm. 37, pp. 9975-9980

  2. Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

    Chemical Record, Vol. 21, Núm. 1, pp. 162-174

2020

  1. Triazolopyridopyrimidine: A new scaffold for dual-target small molecules for Alzheimer's disease therapy

    Molecules, Vol. 25, Núm. 14

2019

  1. Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy

    Bioorganic Chemistry, Vol. 91

  2. New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition

    Journal of Medicinal Chemistry, Vol. 62, Núm. 24, pp. 11416-11422

  3. Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 163-170

  4. Synthesis of (±)-cis-1-Aryl-3-oxo-2,3-dihydro-1H-benzo[f]chromene-2-carbonitriles and (±)-trans-4-Aryl-2-oxo-3,4-dihydro-2H-benzo[h]chromene-3-carbonitriles

    ChemistrySelect, Vol. 4, Núm. 44, pp. 12902-12905

2018

  1. Synthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease Therapy

    ChemistrySelect, Vol. 3, Núm. 2, pp. 461-466

2017

  1. Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapy

    Future Medicinal Chemistry, Vol. 9, Núm. 8, pp. 715-721

  2. Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy

    European Journal of Medicinal Chemistry, Vol. 126, pp. 576-589

2016

  1. Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1−42Aggregation Inhibitors for Alzheimer's Disease Therapy

    ChemMedChem, pp. 1318-1327

  2. Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's disease

    Molecules, Vol. 21, Núm. 5

2012

  1. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 54, pp. 750-763